CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $814,975
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | Derby Michael Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2023-07-14 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2023-07-14 | Olds Donald Director | Grant or award · Stock Options (Right to Buy) | +12,500 | 12,500 | ||
| 2023-07-14 | Macdonald R. Loch Chief Medical Officer | Grant or award · Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2023-07-14 | D'Andrea Carrie VP Clinical Operations | Grant or award · Stock Options (Right to Buy) | +42,000 | 42,000 | ||
| 2023-07-14 | Kumar Amresh VP Program Management | Grant or award · Stock Options (Right to Buy) | +42,000 | 42,000 | ||
| 2023-07-14 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +208,334 | 208,334 | ||
| 2022-09-28 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2022-09-28 | Olds Donald Director | Grant or award · Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2022-09-28 | Canan John Director | Grant or award · Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2022-09-28 | Derby Michael Director | Grant or award · Stock Options (Right to Buy) | +85,000 | 85,000 | ||
| 2022-06-22 | Lemieux Pierre COO, Canada & CSO | Grant or award · Stock Options (Right to Buy) | +165,000 | 165,000 | ||
| 2022-06-22 | Kottayil George COO, US | Grant or award · 06/22/2022 | +50,000 | 50,000 | ||
| 2022-06-22 | Ford Brian D. CHIEF FINANCIAL OFFICER | Grant or award · Stock Options (Right to Buy) | +165,000 | 165,000 | ||
| 2022-06-22 | D'Alvise Janelle PRESIDENT & CEO | Grant or award · Stock Options (Right to Buy) | +560,000 | 560,000 | ||
| 2021-11-12 | Olds Donald Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 | ||
| 2021-11-12 | Lemieux Pierre COO, Canada & CSO | Grant or award · Stock Options (Right to Buy) | +287,900 | 287,900 | ||
| 2021-11-12 | Kavuru Vimal Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 | ||
| 2021-11-12 | HASELTINE WILLIAM A Director | Grant or award · Stock Options (Right to Buy) | +42,100 | 42,100 | ||
| 2021-11-12 | Ford Brian D. CHIEF FINANCIAL OFFICER | Grant or award · Stock Options (Right to Buy) | +287,900 | 287,900 |
Page 4 of 5 · 83 trades